Credit Acceptance Reaches New 52-Week High (CACC)

NEW YORK ( TheStreet) -- Credit Acceptance Corporation (Nasdaq: CACC) hit a new 52-week high Monday as it is currently trading at $101, above its previous 52-week high of $100.95 with 7,415 shares traded as of 11:28 a.m. ET. Average volume has been 27,100 shares over the past 30 days.

Credit Acceptance has a market cap of $2.09 billion and is part of the financial sector and financial services industry. Shares are up 21.2% year to date as of the close of trading on Friday.

Credit Acceptance Corporation, together with its subsidiaries, provides auto loans, and related products and services to consumers in the United States. The company has a P/E ratio of 14.1, above the average financial services industry P/E ratio of 11.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Credit Acceptance as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Credit Acceptance Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

I Believe 'Ugly' Would Be the Proper Term for the Selloff: Market Recon

I Believe 'Ugly' Would Be the Proper Term for the Selloff: Market Recon

4 Stocks That Could Be Turning 'Toxic'

4 Stocks That Could Be Turning 'Toxic'

These 4 Stocks Could Be Toxic to Your Portfolio in 2017

These 4 Stocks Could Be Toxic to Your Portfolio in 2017